Search research articles
Contact Us
Filters
Showing results (1-10 of 59) with videos related to
Page
of 6
Sort By:
Current Pharmaceutical Design
|
June 3, 2017
Parasite Polyamines as Pharmaceutical Targets
Sigrid Roberts, Buddy Ullman
The Journal of Biological Chemistry
|
April 6, 2010
Amplification of adenine phosphoribosyltransferase suppresses the conditionally lethal growth and virulence phenotype of Leishmania donovani mutants lacking both hypoxanthine-guanine and xanthine phosphoribosyltransferases
Jan M Boitz, Buddy Ullman
The Journal of Biological Chemistry
|
January 6, 2005
Identification and characterization of a polyamine permease from the protozoan parasite Leishmania major
Marie-Pierre Hasne, Buddy Ullman
Cell Host & Microbe
|
January 22, 2013
How Trypanosoma cruzi feasts upon its mammalian host
Nicola S Carter, Buddy Ullman
Methods in Molecular Biology (Clifton, N.J.)
|
February 15, 2011
Genetic and biochemical analysis of protozoal polyamine transporters
Marie-Pierre Hasne, Buddy Ullman
Molecular and Biochemical Parasitology
|
April 7, 2006
Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages
Jan M Boitz, Buddy Ullman
Molecular and Biochemical Parasitology
|
July 13, 2013
Adenine and adenosine salvage in Leishmania donovani
Jan M Boitz, Buddy Ullman
The Journal of Biological Chemistry
|
December 29, 2009
Role of transmembrane domain 4 in ligand permeation by Crithidia fasciculata equilibrative nucleoside transporter 2 (CfNT2)
Cassandra S Arendt, Buddy Ullman
The Journal of Biological Chemistry
|
April 11, 2006
A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani
Jan M Boitz, Buddy Ullman
Molecular and Biochemical Parasitology
|
August 2, 2006
Adenosine kinase from Cryptosporidium parvum
Jon Galazka, Boris Striepen, Buddy Ullman
Page
of 6
Search research articles
Search
Showing results (1-10 of 59) with videos related to
Sort By:
Page
of 6
Current Pharmaceutical Design
|
June 3, 2017
Parasite Polyamines as Pharmaceutical Targets
Sigrid Roberts, Buddy Ullman
The Journal of Biological Chemistry
|
April 6, 2010
Amplification of adenine phosphoribosyltransferase suppresses the conditionally lethal growth and virulence phenotype of Leishmania donovani mutants lacking both hypoxanthine-guanine and xanthine phosphoribosyltransferases
Jan M Boitz, Buddy Ullman
The Journal of Biological Chemistry
|
January 6, 2005
Identification and characterization of a polyamine permease from the protozoan parasite Leishmania major
Marie-Pierre Hasne, Buddy Ullman
Cell Host & Microbe
|
January 22, 2013
How Trypanosoma cruzi feasts upon its mammalian host
Nicola S Carter, Buddy Ullman
Methods in Molecular Biology (Clifton, N.J.)
|
February 15, 2011
Genetic and biochemical analysis of protozoal polyamine transporters
Marie-Pierre Hasne, Buddy Ullman
Molecular and Biochemical Parasitology
|
April 7, 2006
Leishmania donovani singly deficient in HGPRT, APRT or XPRT are viable in vitro and within mammalian macrophages
Jan M Boitz, Buddy Ullman
Molecular and Biochemical Parasitology
|
July 13, 2013
Adenine and adenosine salvage in Leishmania donovani
Jan M Boitz, Buddy Ullman
The Journal of Biological Chemistry
|
December 29, 2009
Role of transmembrane domain 4 in ligand permeation by Crithidia fasciculata equilibrative nucleoside transporter 2 (CfNT2)
Cassandra S Arendt, Buddy Ullman
The Journal of Biological Chemistry
|
April 11, 2006
A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani
Jan M Boitz, Buddy Ullman
Molecular and Biochemical Parasitology
|
August 2, 2006
Adenosine kinase from Cryptosporidium parvum
Jon Galazka, Boris Striepen, Buddy Ullman
Page
of 6